ClinicalTrials.govpublic full text
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
dyslipidemia, lcp-atorfen, non-hdl cholesterol, triglycerides, hdl cholesterol, ldl cholesterol, atorvastatin, fenofibrate, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827453
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.